Skip to main content
. 2020 Dec 2;11:608492. doi: 10.3389/fimmu.2020.608492

Figure 1.

Figure 1

Mechanism of action of emapalumab. The drug binds to both free and receptor-bound IFNγ, inhibiting both receptor dimerization and signal transduction via JAK-STAT pathway.